News
Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing ...
New research has found that GLP-1 drugs can substantially reduce the risk of obesity-related cancers — and they’re more ...
2d
NewsNation on MSNStudy: Weight loss drugs could reduce cancer riskThe data showed patients who took GLP-1 drugs had a much lower risk of developing cancer than those who took DDP-4s.
Excess body weight can raise the risk of certain cancers, leading researchers to wonder whether blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in cancer prevention.
Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related ...
That is the kind of half-joking question that doctors kick around when a new class of drugs begins to help a big chunk of the ...
Weight-loss injections could cut the risk of cancer by almost half, research suggests. Researchers analysed the health ...
Mounjaro, Ozempic and other fat-melting injections ... no medications have been proven to lower the cancer risk associated with obesity. 'Our study begins to fill that gap by evaluating GLP ...
Research has found that weight-loss drugs such as Ozempic may help curb addictive behaviours, such as alcohol addiction. One ...
Weight-loss drugs and bariatric surgery both have an impact on cancer risk. A new study breaks down the link and how GLP-1 ...
Excess body weight can raise the risk of certain cancers, leading researchers to wonder whether blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in cancer prevention.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results